IN2013MU01159A - - Google Patents

Info

Publication number
IN2013MU01159A
IN2013MU01159A IN1159MU2013A IN2013MU01159A IN 2013MU01159 A IN2013MU01159 A IN 2013MU01159A IN 1159MU2013 A IN1159MU2013 A IN 1159MU2013A IN 2013MU01159 A IN2013MU01159 A IN 2013MU01159A
Authority
IN
India
Prior art keywords
metformin
salts
compositions
sitagliptin
present
Prior art date
Application number
Inventor
Girish Kumar Jain
Venkataramana Naidu
Atul Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/060029 priority Critical patent/WO2014167437A1/en
Priority to US14/766,753 priority patent/US20150374688A1/en
Priority to IN1159MU2013 priority patent/IN2013MU01159A/en
Priority to EP14721970.3A priority patent/EP3033075A1/en
Publication of IN2013MU01159A publication Critical patent/IN2013MU01159A/en

Links

Abstract

The present invention provides solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to a multilayered coated pharmaceutical composition comprising at least two compartments of metformin or salts thereof exhibiting immediate and extended release and at least one compartment of sitagliptin and metformin or salts thereof exhibiting immediate release. The invention also includes process of preparing such compositions and method of use of such compositions for treating type II diabetes.
IN1159MU2013 2013-03-26 2014-03-21 IN2013MU01159A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/IB2014/060029 WO2014167437A1 (en) 2013-03-26 2014-03-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
US14/766,753 US20150374688A1 (en) 2013-03-26 2014-03-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof.
IN1159MU2013 IN2013MU01159A (en) 2013-03-26 2014-03-21
EP14721970.3A EP3033075A1 (en) 2013-03-26 2014-03-21 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1159MU2013 IN2013MU01159A (en) 2013-03-26 2014-03-21

Publications (1)

Publication Number Publication Date
IN2013MU01159A true IN2013MU01159A (en) 2015-04-24

Family

ID=54395446

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1159MU2013 IN2013MU01159A (en) 2013-03-26 2014-03-21

Country Status (1)

Country Link
IN (1) IN2013MU01159A (en)

Similar Documents

Publication Publication Date Title
DOP2017000109A (en) DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES
PH12015500780A1 (en) Rsv antiviral compounds
TN2015000278A1 (en) Autotaxin inhibitors
IL231591A0 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
SG11201601363YA (en) Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid
PH12016501807A1 (en) Novel compounds
PH12015501609A1 (en) Phenicol antibacterials
CL2014000849A1 (en) Compounds derived from substituted benzylindazoles, bub1 kinase inhibitors; manufacturing procedure; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of hyperproliferative diseases.
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2015011359A (en) Macrocyclic lrrk2 kinase inhibitors.
CL2014002845A1 (en) Compounds derived from pyrazole sglt1 inhibitors; method to treat diabetes; pharmaceutical composition; use of the compound for the treatment of type 1 and type 2 diabetes.
PH12015502747A1 (en) Novel compounds for the treatment of cancer
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
MX2015014958A (en) Novel triazolone derivatives or salts thereof and pharmaceutical composition comprising the same.
EP3694629A4 (en) Composition containing urea for use in brine formation
WO2016020408A3 (en) Compounds for preventing ototoxicity
IN2013MU01158A (en)
IN2013MU01159A (en)
MX360040B (en) Novel phenicol antibacterial agents.
NZ717880A (en) Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors
IN2013MU01224A (en)
IN2013MU01225A (en)
IN2013MU01222A (en)